Prevalence and clinical determinants of diabetic gastroparesis in type 2 diabetes: a symptom- and scintigraphy-based cross-sectional study - Summary - MDSpire

Prevalence and clinical determinants of diabetic gastroparesis in type 2 diabetes: a symptom- and scintigraphy-based cross-sectional study

  • By

  • Marwa M Abokresha

  • Mena Adley Wahba Tousb

  • Manal Esayed Ez Elden

  • Waleed Ahmed Diab

  • Bahaa O Taha

  • June 16, 2026

  • 0 min

Share

Objective:

To identify clinical manifestations and risk variables associated with diabetic gastroparesis in individuals with type 2 diabetes (T2D) and to assess the diagnostic accuracy of the Gastroparesis Cardinal Symptom Index (GCSI) compared to gastric scintigraphy.

Approach:
    Key Findings:
    • Diabetic gastroparesis is underdiagnosed in T2D, with symptoms often misattributed to other gastrointestinal conditions.
    • Risk factors for diabetic gastroparesis include female gender, longer diabetes duration, poor glycemic control, obesity, and diabetic microvascular complications.
    Interpretation:

    The study highlights the need for improved recognition and understanding of diabetic gastroparesis in T2D patients, given its potential impact on quality of life.

    Limitations:
    • The study is limited to a single outpatient clinic, which may affect the generalizability of the findings.
    • The reliance on self-reported symptoms and the potential for selection bias in participant recruitment.
    Conclusion:

    The study aims to bridge gaps in understanding diabetic gastroparesis in T2D through symptom assessment and objective measurement.

Original Source(s)

Related Content